New trends in tumor biology: Transfection of a human hepatoblastoma cell line with green fluorescent protein

Journal of Pediatric Surgery

Volumn 40, Issue 4, 2005, Pages 653-657

  Warmann, Steven W ^a   Fuchs, Jörg ^a   Seitz, Guido ^a   Ruck, Peter ^b   Treuner, Claudia ^a   Mahrt, Jens ^c   Müller, Gerhard A ^c   Wessels, Johannes T ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Krankenhaus Leonberg   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

eGFP transfected human hepatoblastoma; Enhanced green flourescent protein; Vector transfection

Indexed keywords

ANTIBIOTIC G 418; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOLOGY; CANCER RESEARCH; CELL LINE; CELL SELECTION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 17044430182     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2004.12.010     Document Type: Article

References (30)

1. J. Mann, N. Kasthuri, and F. Raafat Malignant hepatic tumors in children: incidence, clinical features and aetiology Paediatr. Perinat. Epidemiol. 4 1990 276 289
2. J. Ross, and J. Gurney Hepatoblastoma incidence in the United States from 1973 to 1992 Med. Pediatr. Oncol. 30 1998 141 142
3. W.S. Park, R.R. Oh, and J.Y. Park Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma J. Pathol. 193 2001 483 490
4. S. Warmann, G. Göhring, and B. Teichmann MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitro J. Pediatr. Surg. 37 2002 1579 1584
5. J. Fuchs, G. Habild, and I. Leuschner Paclitaxel: an effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma Med. Pediatr. Oncol. 32 1999 209 215
6. J. Fuchs, M. Wenderoth, and D. von Schweinitz Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin and etoposide in heterotransplanted hepatoblastoma Cancer 11 1998 2400 2407
7. D.C. Prasher, V.K. Eckenrode, and W.W. Ward Primary structure of the Aequorea victoria green fluorescent protein Gene 111 1992 229 233
8. M. Chalfie, Y. Tu, and G. Euskirchen Green fluorescent protein as a marker for gene expression Science 263 1994 802 805
9. S. Inouye, and F.I. Tsuji Aequorea green fluorescent protein: expression of the gene and fluorescent characteristics of the recombinant protein FEBS Lett. 341 1994 277 280
10. B. Cormack, R.H. Valdivia, and S. Falkow FACS-optimized mutants of the green fluorescent protein (GFP) Gene 173 1996 33 38
11. M.L. Blokpoel, R. O'Toole, and M.J. Smeulders Development and application of unstable GFP variants to kinetic studies of mycobacterial gene expression J. Microbiol. Methods 54 2003 203 211
12. H.A. Richards, M.D. Halfhill, and R.J. Millwood Quantitative GFP fluorescence as an indicator of recombinant protein synthesis in transgenic plants Plant Cell. Rep. 22 2003 117 121
13. W.C. Tseng, F.R. Haselton, and T.D. Giorgio Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression J. Biol. Chem. 272 1997 25641 25647
14. R.M. Hoffman Green fluorescent protein imaging of tumor growth, metastasis and angiogenesis in mouse models Lancet Oncol. 3 2002 546 556
15. M. Bouvel, J.W. Wang, and S.R. Nardin Real time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model Cancer Res. 62 2002 1534 1540
16. I. Doi Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma Gann 67 1976 1 10
17. S.J. Delatte, D.J. Hazen-Martin, and G.G. Re Restoration of p53 function in anaplastic Wilms' tumor J. Pediatr. Surg. 36 2001 43 50
18. E.S. Kim, A. Serur, and J. Huang Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma Proc. Natl. Acad. Sci. U. S. A. 99 2002 11399 11404
19. K. Nienhaus, B. Vallone, and F. Renzi Crystallization and preliminary X-ray diffraction analysis of the red fluorescent protein eqFP611 Acta Crystallogr. D Biol. Crystallogr. 59 2003 1253 1255
20. A. Temme, M. Rieger, and F. Reber Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell Mol. Biol. Cell. 14 2003 78 92
21. P.K. Horan, and S.E. Slezak Stable cell membrane labelling Nature 340 1989 167 168
22. M.J. Melnicoff, P.K. Horan, and P.S. Morahan Kinetics of changes in peritoneal cell populations following acute inflammation Cell. Immunol. 118 1989 178 191
23. G.A. Dabiri, J.C. Ayoob, and K.K. Turnacioglu Use of GFP linked to cytoskeletal proteins to analyse myofibrillogenesis in living cells Methods Enzymol. 302 1999 171 186
24. L. Hunt, P. Batard, and M. Jordan Fluorescent proteins in animal cells for process development: optimization of sodium butyrate treatment as an example Biotechnol. Bioeng. 77 2002 528 537
25. U. Schleicher, M. Rollinghoff, and A. Gessner A stable marker for specific T-cells: a TCR alpha/green fluorescent protein (GFP) fusionprotein reconstitutes a functionally active TCR complex J. Immunol. Methods 246 2000 165 174
26. M. Yamamoto, M. Yang, and P. Jiang Real time GFP imaging of spontaneous HT-1080 fibrosarcoma lung metastases Clin. Exp. Metastasis 20 2003 181 185
27. M. Yang, E. Baranov, and X.M. Li Whole body and intravital optical imaging of angiogenesis in orthotopically implanted tumors Proc. Natl. Acad. Sci. U. S. A. 98 2001 2616 2621
28. J. Fuchs, D. Schmidt, and T. Pietsch Successful transplantation of human hepatoblastoma into immunodeficient mice J. Pediatr. Surg. 31 1996 1241 1249
29. A.B. Glinskii, B.A. Smith, and P. Jiang Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models Cancer Res. 63 2003 4239 4243
30. M.U. Katz, D.E. Spivach, and S. Takimoto Gene therapy of pancreatic cancer with GFP and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter Ann. Surg. Oncol. 10 2003 762 772